METHODS: This is a retrospective analysis of 63 patients with a suspicion of ovarian cancer who reported to Bezmialem University Hospital between 2014 and 2021, underwent ultrasound-guided acid ...

Want to reduce your risk of neck pain and promote overall well-being? Study warns against screen-based sedentary behaviours, like phone and computer use. Women and employees, such as office ...

If you are constantly glued to your phone with your head tilted down, you might be setting yourself up for 'text neck'- a real pain (literally!) caused by bad posture and too much screen time. Text ...

In another review, researchers analysed 610 studies on seeding in biopsies of the head or neck, finding that seeding was extremely rare. Weighing the risks and benefits of getting a biopsy Herbst said ...

A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and ...

The Pittsburgh Steelers will release 2024 sixth-round pick Ryan Watts due to a neck injury he suffered in a preseason game against the Detroit Lions last year. In a statement, Steelers general ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain head and neck cancers from returning. Continuous use of Keytruda ...

I hope for a quick regulatory approval for this new treatment option for patients with head and neck cancer.” Laura Marston ... wasn’t disappearing she saw her GP who referred her for a biopsy, five ...

An immunotherapy treatment has been found to ‘change the world’ for head and neck cancer patients by giving them an extra two and a half years before the disease worsens or comes back.

Please provide your email address to receive an email when new articles are posted on . Adding perioperative pembrolizumab to standard of care significantly improved EFS for patients with advanced ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck squamous cell carcinoma (HNSCC) prolonged event-free survival (EFS), the ...

The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23. Merck’s blockbuster PD-1 inhibitor Keytruda elicited significant survival ...